Skip to content

Darunavir/ritonavir, etravirine and raltegravir combination has 'remarkable' success in children with resistant virus

Nurse prescribing of ARVs: evidence of success in Rwanda and Lesotho

Cost-effective ways to reduce loss to follow-up in ART programmes identified

Transmitted drug-resistant HIV stabilising in Europe

Warning issued about rare etravirine allergic reactions

Study rates Luxembourg as having the best HIV prevention and care in Europe

Etravirine, darunavir/ritonavir and raltegravir very effective in highly treatment-experienced patients

Rifabutin dose inadequate alongside Kaletra

Discovery of enzyme structure points way to creating less toxic anti-HIV drugs